Increased sRAGE production and release in RA patients with high disease activity may be a compensatory anti-inflammatory mechanism in response to tissue damage, as it has the ability to bind ligands and prevent them from activating detrimental signaling pathways. Here, AGER is linked to rheumatoid arthritis.